HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DNA flow cytometric analysis of hemangiopericytoma.

Abstract
The biologic behavior of hemangiopericytoma is difficult to predict using clinical or histologic criteria. The authors studied 22 hemangiopericytomas (including "angioblastic meningiomas") from 16 patients. Included in the study were six recurrent tumors and one metastatic tumor. DNA flow cytometric analysis was performed on 21 tumors for which paraffin-embedded material was available. All of the tumors were DNA diploid. However, among patients with adequate follow-up information, all tumors that exhibited aggressive behavior (local recurrence, metastasis, death due to invasive disease) had S-phase fractions of greater than 9% and proliferative indices (S-phase plus G2M phase) of greater than 11%. There was also a trend toward aggressive behavior in tumors with necrotic foci. Tumors arising in the central nervous system behaved more aggressively than primary tumors at other sites. This study showed a trend toward more aggressive behavior in hemangiopericytomas with higher proliferative indices. DNA ploidy, however, was not a useful indicator of biologic behavior in these tumors.
AuthorsW G Finn, C L Goolsby, M S Rao
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 101 Issue 2 Pg. 181-5 (Feb 1994) ISSN: 0002-9173 [Print] England
PMID8116573 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Adult
  • Aged
  • Cell Division
  • Central Nervous System Neoplasms (genetics, pathology)
  • DNA, Neoplasm (analysis, metabolism)
  • Female
  • Flow Cytometry
  • Hemangiopericytoma (genetics, pathology)
  • Humans
  • Male
  • Meningioma (genetics, pathology)
  • Middle Aged
  • Pelvic Neoplasms (genetics, pathology)
  • Phenotype
  • Ploidies
  • S Phase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: